Skip to content
Cambridge
Design
Partnership
    • Consumer Healthcare
    • Consumer Technology
    • Diagnostics
    • Drug Delivery
    • FMCG
    • Industrial
    • Medical Therapy
    • Tobacco Harm Reduction
    • Applied Science
    • Data Science & Digital Service
    • Insight & Strategy
    • People-Centered Design
    • Product Engineering
    • Quality & Regulatory Affairs
    • Sustainability
    • Testing & Evaluation
    • Transfer to Manufacture
  • Our Work
  • Insights
  • How we work
  • Company
    • Benefits
    • Bourn Quarter
    • Early careers
    • Join our team
    • FAQs & top tips
    • What to expect
  • Contact

Category: Analysis

cell therapies
Analysis

To scale-up or scale-out? The challenge of commercialising cell therapies

11 Jul 2017

Regenerative medicine and cell therapies have long been hailed as the holy-grail of medical treatment. Treatments that use the patient’s own cells to fight disease or regenerate damaged tissues sound like science fiction, however in research institutions around the world this is exactly what is happening 1, 2.  For now though,…

Analysis

How to overcome four major obstacles to healthcare innovation

6 Jul 2017

The world has become information rich and hyper connected, but the promised benefits of integrating our 21st century technology into healthcare have not yet been fully realised. Innovation in some healthcare sectors is rightly perceived from the outside, to reflect a bi-gone era; lacking the pace of change in other…

Analysis

How to succeed as a ‘Year in Industry’ students without burning the place down

2 Jun 2017

Cambridge Design Partnership regularly hosts two trainees from the Engineering Development Trust’s ‘Year in Industry’ scheme. This offers students who are between A-levels and university a year of industrial experience. As we come to the end of our year we have written about our experiences.Being two girls, fresh out of…

Analysis

It’s time to better understand the patient please

1 Jun 2017

Recently, a major drug distributor announced that it would offer refunds to any patient that suffered a heart attack whilst being prescribed their latest cholesterol-lowering drug; this is essentially the refund based business model that has previously been conceptualised and debated in the healthcare industry. There are many considerations to…

Analysis

What ‘job’ is your customer trying to get done?

24 May 2017

It sounds like the simplest question in the world. The answer should come naturally to the most junior marketer or designer in product or service companies. And yet most likely the response will reference an existing product… drill a hole, nebulise a drug, mop the floor, play a cd…, rather…

Analysis

RDD 2017 – Connectivity and medication adherence

18 May 2017

Last month I had the opportunity to spend the week in the South of France. But instead of catching up on some much needed Vitamin D, I joined other industry experts in the world of  Respiratory Drug Delivery (RDD) at the 2017 conference in Nice. One of the main themes running…

Analysis

The future of digital healthcare

11 May 2017

The digital future world is one where we genuinely feel in control and central to our own healthcare. Where we’re engaged and those that interact with us are trusted to provide timely, appropriate and effective support. I recently attended an event at the House of Lords, led by Kai Gait,…

Key trends from the American College of Cardiology Conference
Analysis

Key trends from the American College of Cardiology Conference

11 Apr 2017

Reflections on two themes from the day; – Usability: Continuity from marketing, through R&D, to regulatory– Connected devices and systems: Realising the benefits Usability: Continuity from marketing, through R&D, to regulatoryWe were struck by the frequency at which we heard terms like “usability,” “workflow” and “seamless integration” during presentations on…

5 insights into youth market
Analysis

5 insights into youth markets

7 Apr 2017

Voxburner’s London Youth Marketing Seminar 2017 may not be the first place three consultants from a product innovation firm would be expected to be found, but after……2 days…12 cups of coffee…1 Graffiti Life mural…50 #yms17 tweets, 63 retweets, 144 likes @annie_fc @BenKubler…What can we learn to help us innovate for…

Analysis

Meet Caroline: Drug delivery devices expert

6 Apr 2017

Meet the team at Cambridge Design Partnership – a brief profile of the experts, engineers and interesting people that work here. This month we’re talking to Caroline Zakrzewski, a drug delivery devices expert.1. Why did you join Cambridge Design Partnership?I’ve been very lucky in my career to have worked on…

Analysis

First principles of biomedical engineering – they’re closer than you think

5 Apr 2017

It’s important to realise that beyond the realm of classical engineering principles lays the softer, squishier world of biology and medicine. By being intimately familiar with human anatomy, biomedical engineers are able to more rapidly question whether their concepts are truly viable prior to embarking on further development, using an…

Analysis

Can lasers improve your manufacturing efficiency?

23 Mar 2017

In the last 20 years, evolution in laser technology has lowered cost, improved performance and reliability and made a wide range of laser types available and accessible for industrial applications. Lasers produce an intense and coherent beam of light that can be focused to heat or vaporise a substrate. Different…

Posts navigation

  • «
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
US OFFICE
801 West Morgan Street
Suite 120, Raleigh, NC 27603
+1 (919) 901 0909
UK OFFICE
Bourn Quarter, Wellington Way, Caldecote, Cambridge CB23 7FW
+44 (0)1223 264428
Cookie Policy | Privacy Policy | UK Gender Pay Gap
© Cambridge Design Partnership Ltd 2025. Registered in England and Wales No. GB6786351.